Jan Hauke

20PUBLICATIONS
290CO-AUTHORS
Haematological tumoursCancer geneticsGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 15, 2026
JAK2<sup>V617F</sup>-positive clonal hematopoiesis in germline BRCA1 versus BRCA2 mutation carriers.

|Jun 12, 2026
Constitutional <i>BRCA1</i> Promoter Methylation in Patients With Ovarian Cancer: Results of the Observational AGO-TR1 Study.

|May 14, 2026
Updated ENIGMA recommendations for reporting germline variants in cancer susceptibility genes and their translation into twenty languages.

|Nov 20, 2025
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer.

Daniel R Barnes, Jonathan P Tyrer, Joe Dennis

|Mar 19, 2025
Reclassification of ATM Missense Variants of Uncertain Significance by Integrating Results from Systematic Functional Assays into an ACMG Points-Based Framework.

Helmut Hanenberg, Fan Zhang, Nikita Malev

|Feb 25, 2025
Neoadjuvant Paclitaxel/Olaparib in Comparison to Paclitaxel/Carboplatin in Patients with HER2-Negative Breast Cancer and HRD-Long-term Survival of the GeparOLA Study.

Peter A Fasching, Sabine Schmatloch, Jan Hauke

Pageof 4

Frequent Collaborators

10 joint publications

Eric Hahnen

7 joint publications

Corinna Ernst

7 joint publications

Christoph Engel

5 joint publications

Ana Vega